Article
Novel mutant human fibronectin FIII9-10 domain pair with increased conformational stability and biological activity.
Protein engineering - 1 Dec 2002
van der Walle Christopher F, Altroff Harri, Mardon Helen J
Abstract excerpt
The ninth and tenth type III domains (FIII9-10) in the central cell binding domain of human fibronectin contain integrin receptor binding sites, including RGD in FIII10 and a synergy site, PHSRN, in FIII9. The specific amino acids that contribute to cell binding have been identified by the use of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
